Cargando…
Reactive perforating collagenosis successfully treated with dupilumab
Autores principales: | Gil‐Lianes, Javier, Riquelme‐Mc Loughlin, Constanza, Mascaró, Jose Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544964/ https://www.ncbi.nlm.nih.gov/pubmed/35633371 http://dx.doi.org/10.1111/ajd.13874 |
Ejemplares similares
-
Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation
por: Liu, Ben, et al.
Publicado: (2023) -
Dermoscopic Patterns of Acquired Reactive Perforating Collagenosis
por: Elmas, Ömer Faruk, et al.
Publicado: (2020) -
Reactive perforating collagenosis
por: Arora, Sandeep, et al.
Publicado: (2016) -
Trauma-induced acquired reactive perforating collagenosis()()
por: Gontijo, João Renato Vianna, et al.
Publicado: (2021) -
Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD
por: Ying, Yang, et al.
Publicado: (2021)